HK2-VDAC modulators (ViDAC Pharma)

N/A

Report date: 2025/01/26 15:45:22
NME

Base Information

Drug NameHK2-VDAC modulators (ViDAC Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHexokinase modulators
TargetsHexokinase
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVidac Pharma
China Registration ClassN/A

Develop Information

Active CompaniesVidac Pharma
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A